| Product Code: ETC9002464 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Russia Sartans Market Overview |
3.1 Russia Country Macro Economic Indicators |
3.2 Russia Sartans Market Revenues & Volume, 2021 & 2031F |
3.3 Russia Sartans Market - Industry Life Cycle |
3.4 Russia Sartans Market - Porter's Five Forces |
3.5 Russia Sartans Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Russia Sartans Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Russia Sartans Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Russia Sartans Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of hypertension and cardiovascular diseases in Russia |
4.2.2 Growing awareness about the importance of managing blood pressure |
4.2.3 Rising adoption of sartans due to their efficacy and fewer side effects |
4.3 Market Restraints |
4.3.1 Stringent regulatory environment for pharmaceutical products in Russia |
4.3.2 Competition from alternative blood pressure medications |
4.3.3 Economic instability and fluctuations in healthcare spending |
5 Russia Sartans Market Trends |
6 Russia Sartans Market, By Types |
6.1 Russia Sartans Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Russia Sartans Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Russia Sartans Market Revenues & Volume, By Valsartan, 2021- 2031F |
6.1.4 Russia Sartans Market Revenues & Volume, By Telmisartan, 2021- 2031F |
6.1.5 Russia Sartans Market Revenues & Volume, By Losartan, 2021- 2031F |
6.1.6 Russia Sartans Market Revenues & Volume, By Irbesartan, 2021- 2031F |
6.1.7 Russia Sartans Market Revenues & Volume, By Azilsartan, 2021- 2031F |
6.1.8 Russia Sartans Market Revenues & Volume, By Olmesartan, 2021- 2031F |
6.2 Russia Sartans Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 Russia Sartans Market Revenues & Volume, By Valsartan, 2021- 2031F |
6.2.3 Russia Sartans Market Revenues & Volume, By Telmisartan, 2021- 2031F |
6.2.4 Russia Sartans Market Revenues & Volume, By Losartan, 2021- 2031F |
6.2.5 Russia Sartans Market Revenues & Volume, By Irbesartan, 2021- 2031F |
6.2.6 Russia Sartans Market Revenues & Volume, By Azilsartan, 2021- 2031F |
6.2.7 Russia Sartans Market Revenues & Volume, By Olmesartan, 2021- 2031F |
6.3 Russia Sartans Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Russia Sartans Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Russia Sartans Market Revenues & Volume, By Diagnostic Laboratories, 2021- 2031F |
6.3.4 Russia Sartans Market Revenues & Volume, By Others, 2021- 2031F |
7 Russia Sartans Market Import-Export Trade Statistics |
7.1 Russia Sartans Market Export to Major Countries |
7.2 Russia Sartans Market Imports from Major Countries |
8 Russia Sartans Market Key Performance Indicators |
8.1 Prescription rate of sartans by healthcare providers in Russia |
8.2 Patient adherence to sartan medication regimens |
8.3 Number of clinical trials studying the effectiveness of sartans in Russian populations |
9 Russia Sartans Market - Opportunity Assessment |
9.1 Russia Sartans Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Russia Sartans Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 Russia Sartans Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Russia Sartans Market - Competitive Landscape |
10.1 Russia Sartans Market Revenue Share, By Companies, 2024 |
10.2 Russia Sartans Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |